Tokyo, Japan

Noriyuki Miyata


 

 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Toshima-ku, JP (2007)
  • Tokyo, JP (2003 - 2016)

Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Noriyuki Miyata in the Field of Medicine

Introduction

Noriyuki Miyata, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of medicine through his innovative patents. With a portfolio that includes seven patents, his work primarily focuses on methodologies aimed at treating complex diseases by combining existing therapeutic approaches.

Latest Patents

Among his latest inventions, Miyata developed a patented combination of SGLT 2 inhibitors and antihypertensive drugs. This groundbreaking invention addresses the treatment of diseases linked with hypertension and diabetes mellitus, particularly concerning cardiovascular events. It showcases a superior hypotensive effect that surpasses traditional single antihypertensive medications, mitigating issues commonly associated with using multiple drugs to achieve optimal blood pressure levels. Additionally, his invention proves to be effective in treating diabetes-related complications, especially diabetic nephropathy, while also being beneficial in managing conditions of reduced renal function.

Another notable patent involves the use of 20-HETE synthesizing enzyme inhibitors as a therapeutic method for cerebral vascular diseases. This innovative approach is designed to enhance or maintain cerebral blood flow in both humans and non-human animals by inhibiting enzyme activity associated with 20-HETE synthesis.

Career Highlights

Miyata's impressive career includes working with prominent companies such as Taisho Pharmaceutical Co., Ltd. and McW Research Foundation, Inc. His dedication to research and development in pharmacology has significantly advanced treatment options available to patients suffering from cardiovascular and diabetic complications.

Collaborations

Throughout his career, Miyata has collaborated with esteemed professionals, including Masakazu Sato and Takaaki Ishii. These partnerships have fostered a productive environment for innovation and have led to the development of effective therapeutic solutions.

Conclusion

Noriyuki Miyata exemplifies the spirit of innovation within the medical field. His patents not only provide novel approaches to complex health issues but also reflect a commitment to improving patient care through effective treatments. With a solid foundation of knowledge and experience, Miyata is poised to continue making strides in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…